Duke investigating misconduct?

The Duke University Medical Center has agreed to conduct an inquiry into allegations of misconduct against Duke protein biochemist linkurl:Homme Hellinga,;http://www.biochem.duke.edu/faculty/homme-hellinga according to a linkurl:letter;http://www.nature.com/nature/journal/v454/n7203/full/454397b.html Hellinga wrote to Nature, which was published in the journal this week. Hellinga retracted two papers earlier this year that claimed to have redesigned ribose-binding protein (RBP) to catalyze trio

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Duke University Medical Center has agreed to conduct an inquiry into allegations of misconduct against Duke protein biochemist linkurl:Homme Hellinga,;http://www.biochem.duke.edu/faculty/homme-hellinga according to a linkurl:letter;http://www.nature.com/nature/journal/v454/n7203/full/454397b.html Hellinga wrote to Nature, which was published in the journal this week. Hellinga retracted two papers earlier this year that claimed to have redesigned ribose-binding protein (RBP) to catalyze triose phosphate isomerase (TIM) activity -- a reaction crucial to glycolysis in almost all types of cells. The retractions came after biochemist John Richard, from the State University of New York, Buffalo, tried to replicate the experiments and found that the enzymatic activity of the proteins was from wild-type contamination. In follow up linkurl:letters;http://www.sciencemag.org/cgi/eletters/319/5863/569b published in Science, Richard and another biochemist, John Kirsch from the University of California, Berkeley, wrote that Hellinga's retraction letters did not satisfactorily explain what went wrong in the initial experiments. An linkurl:article;http://www.nature.com/news/2008/080514/full/453275a.html in Nature's news section in May further investigated those claims. (For more on this, read our coverage linkurl:here);http://www.the-scientist.com/blog/display/54502/ In his letter this week, Hellinga writes that Nature's coverage of the retractions and the events following has led to misunderstanding. He wrote: "As my actions have been called into question, I have asked the Duke University Medical Center administration to hold a formal and impartial inquiry into these retractions and the events that have followed. My request has been granted by the university." Hellinga did not respond to an Email and two phone calls requesting comment. Duke University Medical Center refused to confirm or deny that an investigation was underway, but sent a statement to The Scientist that said: "Duke is committed to nurturing and supporting the highest quality science and we review all allegations concerning research integrity according to established procedures. We trust that you and your readers will understand that it would be inappropriate for Duke to comment on any specific proceedings due to confidentiality and other restrictions."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrea Gawrylewski

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo